Suchergebnisse - "Fehn, Karen"

PubPharm (6)

1

Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome : Result of a Phase II Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Gonzalez-Lugo, J. | Kambhampati, S. | Yacoub, A. | +20

2

High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination

enthalten in: Leukemia & lymphoma | 2022

von Shapiro, L. | Thakkar, A. | Gali, R. | +17

3

Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC

enthalten in: JCI insight | 2021

von Yoon, H. | Bartash, R. | Gendlina, I. | +52

UpdateOf: medRxiv. 2020 Dec 04;:. - PMID 33300012

4

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

5

Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2004

von Wadler, S. | Makower, D. | Clairmont, C. | +3

6

A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma

enthalten in: Cancer investigation | 2003

von Makower, D. | Sparano, J. | Wadler, S. | +5

1
[1]